Loring Wolcott & Coolidge Fiduciary Advisors LLP Blueprint Medicines Corp Put Options Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.9 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$587 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$576 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$492 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$371 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$217 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.18B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...